Bit Digital Inc vs Johnson & Johnson — how do they compare? Bit Digital Inc trades at $1.59 (market cap $581.34M), while Johnson & Johnson trades at $248.12 (market cap $611.07B). The key difference: Johnson & Johnson is far larger — about 1051.1× Bit Digital Inc's market cap, and Johnson & Johnson pays a 2.11% dividend while Bit Digital Inc pays none. Which is the better fit depends on your goals.
| BTBT | JNJ | |
|---|---|---|
Market Cap | $581.34M | $611.07B |
Sector | Technology | Health |
52-Week High | $4.22 | $267.24 |
52-Week Low | $1.27 | $155.17 |
Enterprise Value | $870.65M | $644.01B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.11% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson & Johnson (JNJ) trades at $257.77, up 0.31% with a bullish technical signal and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $94.19B, net income margin of 21.83%, and consistent earnings beats. Recent dividend declaration of $1.34 and positive analyst coverage with 52.5% buy ratings reinforce confidence. The current price sits near pivot point resistance at $258, with technical indicators showing bullish momentum from moving averages.
JNJ presents a compelling long-term investment with stable cash flows, strong profitability metrics, and defensive healthcare positioning. Upside potential exists toward the $281 consensus price target, though risks include rising debt-to-asset ratio (24.06% in 2025) and patent expiration headwinds. The stock's 60+ year dividend growth history provides income stability amid market volatility.
Trailing returns across standard periods
Latest headlines on both assets
Bit Digital is a sustainability-focused digital asset production company. It primarily engages in Bitcoin mining and Ethereum staking while also providing high-performance computing (HPC) infrastructure for AI applications.
Read more on BTBT →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →